Aortic Valve Stenosis

• 

  Subject Areas on Research

  • 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. 
  • 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. 
  • 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. 
  • 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. 
  • 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. 
  • 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. 
  • 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. 
  • 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. 
  • 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. 
  • 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. 
  • 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • A Big Headache: An Unusual Case of Hypertensive Urgency in an Adolescent. 
  • A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement. 
  • A novel, data-driven conceptualization for critical left heart obstruction. 
  • A practical guide to multimodality imaging of transcatheter aortic valve replacement. 
  • A previously unreported complication of apicoaortic conduit for severe aortic stenosis. 
  • A rapid, effective technique for retrograde crossing of valvular aortic stenosis using standard coronary catheters. 
  • A reconsideration of Doppler assessed gradients in suspected aortic stenosis. 
  • ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. 
  • ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate use criteria for the treatment of patients with severe aortic stenosis. 
  • ACR Appropriateness Criteria® Imaging for Transcatheter Aortic Valve Replacement. 
  • African American-Caucasian American differences in aortic valve replacement in patients with severe aortic stenosis. 
  • Amplatzer Device Embolization to the Aortic Arch Discovered Two Years After Implantation 
  • An acute animal model of aortic stenosis: initial attempts at leaflet modification. 
  • An infant with subvalvar and valvar aortic stenosis, subvalvar and valvar pulmonary stenosis, severe biventricular hypertrophy and pulmonary hemorrhage. 
  • Analyses of cancer data from three ezetimibe trials. 
  • Analysis of Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement. 
  • Analysis of Neurologic Complications After Surgical Versus Transcatheter Aortic Valve Replacement. 
  • Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in North Carolina. 
  • Analysis of the early rise in aortic transvalvular gradient after aortic valvuloplasty. 
  • Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. 
  • Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. 
  • Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. 
  • Another use for transesophageal echocardiography during aortic valve bypass surgery. 
  • Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed. 
  • Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. 
  • Anxiety and Depression Following Aortic Valve Replacement. 
  • Aortic stenosis and 3-dimensional echocardiography: the saga continues. 
  • Aortic stenosis and coronary artery disease... and a challenging aorta. 
  • Aortic stenosis and mitral regurgitation: not as simple as it looks. 
  • Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. 
  • Aortic valve replacement in a diseased bicuspid valve eleven years after transplantation. 
  • Aortic valve replacement in adults after balloon aortic valvuloplasty. 
  • Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. 
  • Aortic valvular disease. Comparison of types and their medical and surgical management. 
  • Aortic-valve stenosis. 
  • Aortic/mitral obstruction and coarctation of the aorta. 
  • Appropriateness of Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry. 
  • Assessment of Paravalvular Leak After Transcatheter Aortic Valve Replacement: Transesophageal Echocardiography Compared With Transthoracic Echocardiography. 
  • Assessment of anatomy and cardiac function by Doppler echocardiography. 
  • Assessment of atrioventricular conduction in aortic valve disease. 
  • Assessment of single-bolus contrast administration technique using hybrid dual-source ECG-gated thoracic and dual-source non-ECG-gated high-pitch abdominopelvic CT acquisitions for procedural planning before transcatheter aortic valve replacement. 
  • Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes. 
  • Association Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes. 
  • Association Between Patient Survival and Clinician Variability in Treatment Rates for Aortic Valve Stenosis. 
  • Association Between Peripheral Versus Central Access for Alternative Access Transcatheter Aortic Valve Replacement and Mortality and Stroke: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. 
  • Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk. 
  • Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke. 
  • Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement. 
  • Association of Smoking Status With Long-Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement. 
  • Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use. 
  • Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association of Volume and Outcomes in 234 556 Patients Undergoing Surgical Aortic Valve Replacement. 
  • Asymptomatic Severe Aortic Valve Stenosis-When to Intervene: a Review of the Literature, Current Trials, and Guidelines. 
  • Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis. 
  • Balloon Versus Computed Tomography Sizing of the Aortic Annulus for Transcatheter Aortic Valve Replacement and the Impact of Left Ventricular Outflow Tract Calcification and Morphology on Sizing. 
  • Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. 
  • Balloon aortic valvuloplasty. 
  • Bicuspid aortic valve durability with valve-sparing aortic root replacement: comparison to tricuspid valve. 
  • Bicuspid noncalcific aortic stenosis: diagnostic limitations of intraoperative transesophageal echocardiography. 
  • Biplane cineangiographic determinations of left ventricular function: pressure-volume relationships. 
  • Blood Pressure and Arterial Load After Transcatheter Aortic Valve Replacement for Aortic Stenosis. 
  • CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. 
  • Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks. 
  • Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility. 
  • Calcific valvular aortic stenosis with and without mitral anular calcium. 
  • Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? 
  • Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium. 
  • Cardiac conduction system disease after transcatheter aortic valve replacement. 
  • Case 6-2011: Aortic valve replacement in a patient with aortic stenosis, dilated cardiomyopathy, and renal dysfunction. 
  • Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry. 
  • Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management. 
  • Challenges in Aortic Valve Stenosis: Low-Flow States Diagnosis, Management, and a Review of the Current Literature. 
  • Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic Valve Replacement Eras. 
  • Changes in left ventricular diastolic performance after aortic balloon valvuloplasty: acute and late effects. 
  • Changes in left ventricular systolic performance immediately after percutaneous aortic balloon valvuloplasty. 
  • Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2. 
  • Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. I. Myocardial blood flow and metabolism. 
  • Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. II. Response to ischemia. 
  • Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy. 
  • Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 
  • Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. 
  • Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Clinical Outcomes in Different Types of Aortic Stenosis as Assessed by Doppler Echocardiography. 
  • Clinical assessment of ventricular ejection dynamics with and without outflow obstruction. 
  • Clinical auscultation skills in pediatric residents. 
  • Clinical correlates of atrial tachyarrhythmias after valve replacement for aortic stenosis. 
  • Clinical implications of pulmonary hypertension in mitral stenosis. 
  • Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 1: Pluridisciplinary perspective on their hemodynamics and morphomechanics. 
  • Commentary: From 2-dimensional to 3-dimensional-Tailor-made transcatheter aortic valve replacement to minimize complications. 
  • Commentary: Structural abnormalities after Freestyle full aortic root replacement: Time to accept the facts. 
  • Commentary: Thank you, sir, may I TAVI another: Procedural problems and postoperative complications in SURTAVI. 
  • Comparison of echocardiographic methods for assessment of left ventricular shortening and wall stress. 
  • Comparison of simultaneous invasive and noninvasive measurements of pressure gradients in congenital aortic valve stenosis. 
  • Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). 
  • Complementarity and competitiveness of the intrinsic and extrinsic components of the total ventricular load: demonstration after valve replacement in aortic stenosis. 
  • Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. 
  • Complete heart block complicating retrograde left ventricular catheterization: case report and review. 
  • Composite Metric for Benchmarking Site Performance in Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry. 
  • Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function. 
  • Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. 
  • Congenital aortic stenosis and patent ductus arteriosus in the adult. 
  • Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Contemporary Outcomes of Repeat Aortic Valve Replacement: A Benchmark for Transcatheter Valve-in-Valve Procedures. 
  • Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. 
  • Contribution of afterload, hypertrophy and geometry to left ventricular ejection fraction in aortic valve stenosis, pure aortic regurgitation and idiopathic dilated cardiomyopathy. 
  • Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes. 
  • Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study. 
  • Correlation between calcific aortic stenosis diagnosed by two-dimensional echocardiography and cardiac catheterization. 
  • Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. 
  • Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. 
  • Demographics, Procedural Characteristics, and Clinical Outcomes When Cardiogenic Shock Precedes TAVR in the United States. 
  • Determinants of one-year outcome from balloon aortic valvuloplasty. 
  • Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. 
  • Different effects of two types of ischemia on myocardial systolic and diastolic function. 
  • Discordance in Grading Methods of Aortic Stenosis by Pre-Cardiopulmonary Bypass Transesophageal Echocardiography. 
  • Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. 
  • Doppler echocardiographic findings in adults with severe symptomatic valvular aortic stenosis. Balloon Valvuloplasty Registry Echocardiographers. 
  • Doppler left ventricular diastolic filling abnormalities in aortic stenosis and their relation to hemodynamic parameters. 
  • Doppler-detected valve movement in aortic stenosis: a predictor of adverse outcome. 
  • Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. 
  • Early and late changes in left ventricular systolic performance after percutaneous aortic balloon valvuloplasty. 
  • Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: a prospective two-dimensional echocardiographic study. 
  • Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. 
  • Early restenosis following successful percutaneous balloon valvuloplasty for calcific valvular aortic stenosis. 
  • Echocardiographic Imaging for Transcatheter Aortic Valve Replacement. 
  • Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. 
  • Echocardiography in Clinical Trials for TAVR: Getting to the Core of the Matter. 
  • Echocardiography of the aortic valve in non-rheumatic left ventricular outflow tract lesions. 
  • Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. 
  • Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial. 
  • Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. 
  • Effects of valve replacement on ventricular mechanics in mitral regurgitation and aortic stenosis. 
  • Ejection load changes in aortic stenosis. Observations made after balloon aortic valvuloplasty. 
  • Elastic properties of normal and hypertrophied cardiac muscle. 
  • Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. 
  • Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. 
  • Endovascular stenting of the abdominal aorta following renal transplantation. 
  • Epidemiology, evaluation, and management of conduction disturbances after transcatheter aortic valve replacement. 
  • Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement: An STS/ACC TVT Analysis. 
  • Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial. 
  • Evaluation of The Society of Thoracic Surgeons Online Risk Calculator for Assessment of Risk in Patients Presenting for Aortic Valve Replacement After Prior Coronary Artery Bypass Graft: An Analysis Using the STS Adult Cardiac Surgery Database. 
  • Factors Associated With and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement. 
  • Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function. 
  • Fatal fungal infection following open-heart surgery. 
  • Feasibility study of a novel digital health platform for patients undergoing transcatheter aortic valve replacement. 
  • Ferumoxtyol-enhanced MR Angiography for Transcatheter Aortic Valve Replacement Planning in Patients with Renal Failure. 
  • Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial. 
  • Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. 
  • Fluid dynamics of aortic stenosis: mechanisms for the presence of subvalvular pressure gradients. 
  • Fluid dynamics of aortic stenosis: subvalvular gradients without subvalvular obstruction. 
  • Fluoroscopic characterization of surgical bioprosthetic heart valves. 
  • Follow-up recatheterization after balloon aortic valvuloplasty. Mansfield Scientific Aortic Valvuloplasty Registry Investigators. 
  • For TAVR, Home Is Where the Heart Is. 
  • Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. 
  • Fusion of the left aortic cusp to the aoic wall with occlusion of the left coronary ostium, and aortic stenosis and insufficiency. 
  • Futility, benefit, and transcatheter aortic valve replacement. 
  • Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. 
  • Genetic associations with valvular calcification and aortic stenosis. 
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Geographic dispersion of TAVR services: Ensuring availability while maintaining quality. 
  • Grading Aortic Stenosis With Mean Gradient and Aortic Valve Area: A Comparison Between Preoperative Transthoracic and Precardiopulmonary Bypass Transesophageal Echocardiography. 
  • Grand mal seizure during cardiopulmonary bypass: probable lidocaine toxicity. 
  • Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. 
  • Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. 
  • Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry. 
  • Imaging for Predicting and Assessing Prosthesis-Patient Mismatch After Aortic Valve Replacement. 
  • Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve. 
  • Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis. 
  • Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement. 
  • Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation. 
  • Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial. 
  • Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial. 
  • Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. 
  • Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. 
  • Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries. 
  • Impact of short-term complications of transcatheter aortic valve replacement on longer-term outcomes: results from the STS/ACC Transcatheter Valve Therapy Registry. 
  • Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. 
  • Implementing a Continuous Quality Improvement Program in a High-Volume Clinical Echocardiography Laboratory: Improving Care for Patients With Aortic Stenosis. 
  • Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. 
  • In pursuit of perfection: "alive and better" as the measure of procedural success. 
  • Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial. 
  • Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry. 
  • Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). 
  • Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. 
  • Incidence of strict versus nonstrict left bundle branch block after transcatheter aortic valve replacement. 
  • Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology National Cardiovascular Data Registry-Transcatheter Valve Therapy Registry. 
  • Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. 
  • Incidence, Prognosis and Predictors of Major Vascular Complications and Percutaneous Closure Device Failure Following Contemporary Percutaneous Transfemoral Transcatheter Aortic Valve Replacement. 
  • Incidental Cold Agglutinins in Cardiac Surgery: Intraoperative Surprises and Team-Based Problem-Solving Strategies During Cardiopulmonary Bypass. 
  • Increased Ca2+ influx through CaV1.2 drives aortic valve calcification. 
  • Influence of QRS infarct score and QRS duration prior to transcatheter aortic valve replacement on follow-up left ventricular end systolic volume in patients with new persistent left bundle branch block. 
  • Initial Application of a Bicuspid Aortic Annuloplasty Ring in Pediatric Cardiac Surgery. 
  • Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients. 
  • Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. 
  • Intraprocedural Cardiac Complications of Transcatheter Aortic and Mitral Valve Interventions: "The Eyes Do Not See What the Mind Does Not Know". 
  • Invasive hemodynamic evaluation in patients with mechanical aortic valves. Catheterization and cardiovascular interventions: official journal of the society for cardiac angiography & interventions 2013. 
  • Is Transcatheter Aortic Valve Replacement Worth the Wait? 
  • Is the valve OK or not? Immediate evaluation of a replaced aortic valve. 
  • Is this a bridge too far? 
  • JCL Roundtable: Global Think Tank on Lipoprotein(a). 
  • KPT-330 Prevents Aortic Valve Calcification via a Novel C/EBPβ Signaling Pathway. 
  • Kissing stents in the aortic bifurcation. 
  • Know Me! Unraveling the Riddle of Calcific Aortic Valve Disease by Bioinformatics. 
  • Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. 
  • Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. 
  • Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. 
  • Left ventricular performance and clinical outcome after repeat balloon aortic valvuloplasty. 
  • Left ventricular performance improves late after aortic valve replacement in patients with aortic stenosis and reduced ejection fraction. 
  • Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial. 
  • Longitudinal Shortening of the Left Ventricle by Cine-CMR for Assessment of Diastolic Function in Patients with Aortic Valve Disease. 
  • Macrophages Promote Aortic Valve Cell Calcification and Alter STAT3 Splicing. 
  • Mechanisms of Death in Low-Risk Patients After Transcatheter or Surgical Aortic Valve Replacement. 
  • Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive? 
  • Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty. The NHLBI Balloon Valvuloplasty Registry. 
  • Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. 
  • Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. 
  • Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. 
  • Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. 
  • Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone. 
  • Myocardial relaxation and passive diastolic properties in man. 
  • Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. 
  • Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. 
  • New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial. 
  • Nonsurgical management of obstructive aortic thrombosis complicated by renovascular hypertension in the neonate. 
  • On fibrosis, prognosis, and the unique role of CMR: a paradigm shift from "bright is dead" to "bright is bad". 
  • One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis. 
  • Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry. 
  • Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry. 
  • Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. 
  • Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement. 
  • Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). 
  • Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). 
  • Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry. 
  • Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. 
  • Pannus-related prosthetic valve dysfunction and life-threatening aortic regurgitation. 
  • Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study. 
  • Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. 
  • Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacement. 
  • Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. 
  • Percutaneous balloon valvuloplasty of calcific aortic stenosis. 
  • Percutaneous heart valve replacement for aortic stenosis: state of the evidence. 
  • Percutaneous management of RetroFlex 3 balloon rupture and separation of the Edwards Sapien delivery system. 
  • Peripheral vascular complications during transcatheter aortic valve replacement: management and potential role of chronic steroid use. 
  • Porphyrin-Based SOD Mimic MnTnBu OE -2-PyP5+ Inhibits Mechanisms of Aortic Valve Remodeling in Human and Murine Models of Aortic Valve Sclerosis. 
  • Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry. 
  • Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT. 
  • Pre-intervention morphologic and functional echocardiographic characteristics of neonates with critical left heart obstruction: a Congenital Heart Surgeons Society (CHSS) inception cohort study. 
  • Precision Medicine in TAVR: How to Select the Right Device for the Right Patient. 
  • Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population. 
  • Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve Implantation. 
  • Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. 
  • Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction. 
  • Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. 
  • Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease. 
  • Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry. 
  • Prevalence and clinical associations of mitral and aortic regurgitation in patients with aortic stenosis. 
  • Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry. 
  • Procedural Volume and Outcomes for Transcatheter Aortic-Valve Replacement. 
  • Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. 
  • Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. 
  • Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). 
  • Progress in ring array transducers for real-time 3D ultrasound guidance of cardiac interventional devices. 
  • Promoting Early Mobility in Patients After Transcatheter Aortic Valve Replacement: An Evidence-Based Protocol. 
  • Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. 
  • Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry. 
  • Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry. 
  • Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials. 
  • Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of caution. 
  • Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry. 
  • Quantification of Aortic Valve Calcifications Detected During Lung Cancer-Screening CT Helps Stratify Subjects Necessitating Echocardiography for Aortic Stenosis Diagnosis. 
  • Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era. 
  • Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report. 
  • Racial and Ethnic Differences in Treatment and Outcomes of Severe Aortic Stenosis: A Review. 
  • Racial differences in the prevalence of severe aortic stenosis. 
  • Racial disparities and democratization of health care: A focus on TAVR in the United States. 
  • Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas. 
  • Radiation-associated valvular heart disease. 
  • Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. 
  • Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries. 
  • Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry. 
  • Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement. 
  • Relationship of Body Mass Index With Outcomes After Transcatheter Aortic Valve Replacement: Results From the National Cardiovascular Data-STS/ACC TVT Registry. 
  • Relative wall thickness analysis by two-dimensional echocardiography. 
  • Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database. 
  • Reoperation after transcatheter aortic valve replacement: the future is here. 
  • Reply: Improving the Patient Relevance and Generalizability of TAVR Core Data Elements. 
  • Reply: On Evaluating Out-of-Hospital 30-Day Mortality After TAVR. 
  • Reply: Reconsidering Waiting Times in Transcatheter Aortic Valve Replacement: Is There Any No-Return Point? 
  • Reply: Redo SAVR After Primary TAVR, A Dangerous Sequence? 
  • Reply: To PMID 25301369. 
  • Reply: Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease. 
  • Reply: Uncertainty in Uncertainty: How Risky Is Surgical Aortic Valve Replacement After TAVR? 
  • Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. 
  • Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. 
  • Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. 
  • Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation. 
  • Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement. 
  • Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. 
  • Serial assessment of ventricular performance after valve replacement for aortic stenosis. 
  • Serial evaluation of ventricular function after percutaneous aortic balloon valvuloplasty. 
  • Serial left ventricular performance evaluated by cardiac catheterization before, immediately after and at 6 months after balloon aortic valvuloplasty. 
  • Sex disparities in patients with symptomatic severe aortic stenosis. 
  • Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. 
  • Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. 
  • Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). 
  • Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations. 
  • Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry. 
  • Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis. 
  • Sixteen years later and the debate for transcatheter aortic valve replacement or surgical aortic valve replacement remains controversial. 
  • Smoking and TAVR. 
  • Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012-2018. 
  • Staging classification of aortic stenosis based on the extent of cardiac damage. 
  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. 
  • Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. 
  • Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. 
  • Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement. 
  • Stuck with a decision: what is the "true" aortic valve area--anatomic, geometric, or effective orifice area? 
  • Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. 
  • Surgical Aortic Valve Replacement for Failed TAVR Prostheses: One More Piece of the Puzzle. 
  • Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era: Implications for the Heart Team. 
  • Surgical Sutureless and Sutured Aortic Valve Replacement in Low-risk Patients. 
  • Surgical Valvotomy Versus Balloon Valvuloplasty for Congenital Aortic Valve Stenosis: A Systematic Review and Meta-Analysis. 
  • Surgical aortic valvuloplasty using the Cavitron Ultrasonic Surgical Aspirator: an invasive hemodynamic follow-up study. 
  • Surgical repair of atrial septal defect in an 89-year-old man: progressive shunt due to concomitant aortic stenosis. 
  • Symptomatic obstruction of the brachiocephalic and left subclavian arteries obscured by aortic stenosis. 
  • Task Force 3: valvular heart disease. 
  • Temporal Trends in Disease Severity and Predicted Surgical Risk at the Time of Referral for Echocardiography in Patients Diagnosed with Aortic Stenosis. 
  • The Association of Aortic Valve Pathology With Renal Resistive Index as a Kidney Injury Biomarker. 
  • The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement. 
  • The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. 
  • The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR. 
  • The Mind Is Your Best Muscle: TAVR/SAVR Outcomes in Patients With Cognitive Impairment. 
  • The Placement of Aortic Transcatheter Valve (PARTNER) trial: a health economic and policy perspective. 
  • The Value of Transesophageal Echocardiography in Transcatheter Valve Procedures: Is it Still Questionable? 
  • The association of chronic lung disease with early mortality and respiratory adverse events after aortic valve replacement. 
  • The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. 
  • The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers. 
  • The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. 
  • The risk for systemic embolization associated with percutaneous balloon valvuloplasty in adults. A prospective comprehensive evaluation. 
  • Thinking beyond the aortic valve: implications of a diseased aorta. 
  • Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. 
  • To Double Stick or Not to Double Stick? 
  • Trained and supervised physician assistants can safely perform diagnostic cardiac catheterization with coronary angiography. 
  • Transapical Approach for TAVR: Keep It in the Quiver. 
  • Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. 
  • Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. 
  • Transcatheter Aortic Valve Implant Depth Measurements Differ by Aortography Versus Computed Tomography. 
  • Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. 
  • Transcatheter Aortic Valve Replacement After Prior Mitral Valve Surgery: Results From the Transcatheter Valve Therapy Registry. 
  • Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass: A Comparison of Outcomes and Economics. 
  • Transcatheter Aortic Valve Replacement in Intermediate- and Low-Risk Patients. 
  • Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic Stenosis. 
  • Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation. 
  • Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. 
  • Transcatheter Aortic Valve Replacement of Failed Surgically Implanted Bioprostheses: The STS/ACC Registry. 
  • Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. 
  • Transcatheter Leadless Pacemaker Implantation for Complete Heart Block Following CoreValve Transcatheter Aortic Valve Replacement. 
  • Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison. 
  • Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry. 
  • Transcatheter aortic valve implantation (TAVI) in Germany 2008-2014: on its way to standard therapy for aortic valve stenosis in the elderly? 
  • Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF. 
  • Transcatheter aortic valve replacement for aortic bioprosthetic valve failure with cardiogenic shock. 
  • Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis. 
  • Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. 
  • Transcatheter aortic valve replacement valve durability: Good enough for young, low-risk patients? 
  • Transcatheter aortic valve replacement: an update. 
  • Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. 
  • Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. 
  • Transcatheter aortic-valve replacement with a self-expanding prosthesis. 
  • Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. 
  • Transesophageal echocardiography and evaluation of valvular heart disease. 
  • Trends and Outcomes of Alternative-Access Transcatheter Aortic Valve Replacement. 
  • Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. 
  • Two hard lessons. 
  • Two-year outcomes after transcatheter or surgical aortic-valve replacement. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry. 
  • Use of balloon aortic valvuloplasty to size the aortic annulus before implantation of a balloon-expandable transcatheter heart valve. 
  • Using Clinical Decision Support to Improve Referral Rates in Severe Symptomatic Aortic Stenosis: A Quality Improvement Initiative. 
  • Validation of pressure-volume data obtained in patients by initial transit radionuclide angiocardiography. 
  • Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry. 
  • Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Variation in Hospital Risk-Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Vascular and valvar calcification: recent advances. 
  • Visualization of Human Aortic Valve Dynamics Using Magnetic Resonance Imaging with Sub-Millisecond Temporal Resolution. 
  • Who can we save after an intraprocedural catastrophe during TAVR?